We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
-1.95%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
-$24.4M
(-13%)
Cap. Flow
-$26.5M
Cap. Flow
% of AUM
-16.46%
Top 10 Holdings %
Top 10 Hldgs %
38.57%
Holding
407
New
93
Increased
23
Reduced
79
Closed
92
Avg Time Held Equity + Options
2.2
quarters
Top 10 Avg Time Held Equity + Options
1
quarter
Top 20 Avg Time Held Equity + Options
1.7
quarters
Avg Time Held Equity only
2.4
quarters
Top 10 Avg Time Held Equity only
1.7
quarters
Top 20 Avg Time Held Equity only
2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$1.25M |
| 2 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$1.21M |
| 3 |
Wolfspeed
WOLF
|
+$994K |
| 4 |
Taro Pharmaceutical Industries Ltd.
TARO
|
+$888K |
| 5 |
ENDP
Endo International plc
ENDP
|
+$669K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$5.05M |
| 2 |
Hess
HES
|
+$1.8M |
| 3 |
Lindsay Corp
LNN
|
+$1.73M |
| 4 |
Boston Scientific
BSX
|
+$1.63M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.63% |
| 2 | Financials | 31.25% |
| 3 | Healthcare | 9.43% |
| 4 | Technology | 5.38% |
| 5 | Consumer Discretionary | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Century Casinos
CNTY
$23.6M
| $145K | 0.09% |
25,000
| – | – |
2013 Q4
2 quarters
|
|
|
BEL
177
DELISTED
Belmond Ltd.
BEL
| $145K | 0.09% |
10,000
-30,000
| -75% | -$398K |
2013 Q2
4 quarters
|
|
178
DELISTED
KEMET Corporation
KEM
| $144K | 0.09% |
+25,000
| New | +$139K |
2014 Q2
0 quarters
|
|
|
STKL
179
CALL
DELISTED
SunOpta
STKL
| $141K | 0.09% |
+10,000
| New | +$124K |
2014 Q2
0 quarters
|
|
|
CTIC
180
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $141K | 0.09% |
5,000
-5,000
| -50% | -$150K |
2013 Q2
4 quarters
|
|
181
DELISTED
AMERICAN APPAREL INC COM
APP
| $135K | 0.08% |
150,250
-49,750
| -25% | -$30.7K |
2013 Q2
4 quarters
|
|
|
ROX
182
DELISTED
Castle Brands, Inc.
ROX
| $134K | 0.08% |
150,000
| – | – |
2013 Q2
4 quarters
|
|
183
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $131K | 0.08% |
175,000
| – | – |
2013 Q2
4 quarters
|
|
|
PGTI
184
DELISTED
PGT, Inc.
PGTI
| $127K | 0.08% |
+15,000
| New | +$140K |
2014 Q2
0 quarters
|
|
|
INFI
185
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $127K | 0.08% |
+10,000
| New | +$104K |
2014 Q2
0 quarters
|
|
|
HDNG
186
DELISTED
Hardinge Inc
HDNG
| $127K | 0.08% |
10,000
| – | – |
2013 Q2
4 quarters
|
|
187
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $126K | 0.08% |
+10,000
| New | +$81.2K |
2014 Q2
0 quarters
|
|
|
VVTV
188
DELISTED
VALUEVISION MEDIA INC
VVTV
| $125K | 0.08% |
+25,000
| New | +$119K |
2014 Q2
0 quarters
|
|
189
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
| $120K | 0.07% |
20,000
-30,000
| -60% | -$189K |
2013 Q2
4 quarters
|
|
190
CALL
MannKind Corp
MNKD
$1.01B
| $110K | 0.07% |
+2,000
| New | +$80.2K |
2014 Q2
0 quarters
|
|
191
Aldeyra Therapeutics
ALDX
$54.6M
| $105K | 0.07% |
+16,000
| New | +$107K |
2014 Q2
0 quarters
|
|
192
DELISTED
Emcore Corp
EMKR
| $103K | 0.06% |
2,500
| – | – |
2013 Q4
2 quarters
|
|
193
Pure Cycle
PCYO
$271M
| $102K | 0.06% |
15,000
-15,000
| -50% | -$85.7K |
2013 Q2
4 quarters
|
|
|
XWES
194
DELISTED
WORLD ENERGY SOLUTIONS INC NEW COMMON (DE)
XWES
| $100K | 0.06% |
25,000
| – | – |
2013 Q2
4 quarters
|
|
195
Curis
CRIS
$1.56M
| $93K | 0.06% |
25
-13
| -34% | -$52.9K |
2013 Q2
4 quarters
|
|
|
ANR
196
DELISTED
Alpha Natural Resources Inc
ANR
| $93K | 0.06% |
25,000
| – | – |
2013 Q4
2 quarters
|
|
|
NOR
197
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $88K | 0.05% |
+3,571
| New | +$89.2K |
2014 Q2
0 quarters
|
|
198
Fortress Biotech
FBIO
$70.4M
| $86K | 0.05% |
3,333
| – | – |
2013 Q2
4 quarters
|
|
199
CALL
DELISTED
Bazaarvoice, Inc.
BV
| $79K | 0.05% |
+10,000
| New | +$69.9K |
2014 Q2
0 quarters
|
|
200
Viridian Therapeutics
VRDN
$2.07B
| $71K | 0.04% |
+44
| New | +$77.7K |
2014 Q2
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2014 Portfolio in Review
As of Q2 2014, E.E. Geduld held 407 positions worth $161M, down 13% from $185M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
E.E. Geduld withdrew a net $26.5M in Q2 2014, closing 92 positions and reducing 79 holdings. Its most notable exit was Johnson & Johnson, an estimated $5.05M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, E.E. Geduld opened a new position in Atlantica Sustainable Infrastructure plc Ordinary Shares worth $1.25M.
- E.E. Geduld's largest Q2 2014 buy was Atlantica Sustainable Infrastructure plc Ordinary Shares: 33,000 shares worth $1.25M.
- E.E. Geduld added most to FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA) in Q2 2014, an estimated $362K increase.
- E.E. Geduld's biggest Q2 2014 reduction was Hess, cutting an estimated $1.8M.
- E.E. Geduld fully exited Johnson & Johnson in Q2 2014, selling an estimated $5.05M.
- E.E. Geduld's ten largest holdings make up 39% of its $161M portfolio in Q2 2014.
- E.E. Geduld opened 93 new positions and closed 92 in Q2 2014.
- E.E. Geduld's portfolio value fell 13% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2014, filed 4 Aug 2014.